Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03789409
Other study ID # chhwang11
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 4, 2019
Est. completion date January 31, 2021

Study information

Verified date December 2019
Source Ulsan University Hospital
Contact Chang Ho Hwang
Phone +82-52-250-7210
Email chhwang1220ciba@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.


Description:

In order to verify the validity and clinical efficacy of intermittent fasting for neurological and functional effects of ischemic cerebral infarction, the first ischemic stroke (diagnosed within 1 year through brain MRI / CT) patients will be randomly assigned to intermittent fasting group or control group. In both groups, physical therapy, occupational therapy and speech therapy will be provided during 3 hours in total a day. The intermittent fasting group should maintain intermittent fasting for no less than 12 hours or more every day during the rehabilitation period (at least 1 week), and the control group is able to eat all of the hospital meals and all the participants want without any time limit. The efficacy of intermittent fasting is to be verified by performing the electro-physiological tests and functional evaluations before participation, 1st week, 2nd weeks after participation, before discharge, 3 months, and 6 months after the stroke onset.


Recruitment information / eligibility

Status Recruiting
Enrollment 68
Est. completion date January 31, 2021
Est. primary completion date January 31, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Patients who was diagnosed first ischemic stroke within preceeding 1 year through brain MRI/CT

Exclusion Criteria:

- Musculo-skeletal disease with limbs malformation or joint contracture

- Weigh more than 135 kg or taller than 195 cm

- Diabetes mellitus

- unstable patient in neurology

- Refusal of participation

Study Design


Intervention

Dietary Supplement:
Intermittent Fasting
The aforementioned intermittent fasting in arm/group descriptions.

Locations

Country Name City State
Korea, Republic of Ulsan University Hospital Ulsan

Sponsors (1)

Lead Sponsor Collaborator
Ulsan University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Change of Mini mental status exam Mini mental status exam(minimum of 0 and maximum scores of 30); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Beck depression inventory Beck depression inventory(minimum of 0 and maximum scores of 63); higher values and a worse outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Wecsler aphasia battery Wecsler aphasia battery(minimum of 0 and maximum scores of 100); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Berg balance scale Berg balance scale(minimum of 0 and maximum scores of 56); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Functional Ambulation Category Functional Ambulation Category(minimum of 0 and maximum scores of 5); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Motricity Index Motricity Index(minimum of 0 and maximum scores of 99); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of 10m walking test 10m walking test 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Grasping force (kg) Grasping force (kg) 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of 9-hole pegboard 9-hole pegboard 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Jebsen Taylor test Jebsen-Taylor Hand Function Test 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Nottingham sensory scale Nottingham sensory scale(minimum of 0 and maximum scores of 20); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Arm motor Fugl-Mayer scale Arm motor Fugl-Mayer scale; wrist & hand/proximal arm(minimum of 0 and maximum scores of 24 and of 34, respectively ); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Stroke impact scale Hand motor, Stroke Impact Scale (minimum of 12 and maximum scores of 60); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Ashworth scale Ashworth scale; elbow, wrist, knee & ankle(minimum of 0 and maximum scores of 4); higher values and a worse outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Knee joint kinesthesia The smallest iso-kinetic angle from which the participants could detect any passive flexion or extension movement of their own knee, using Biodex; (minimum of 0 and maximum scores of 360 degree); higher values and a worse outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Behavioral inatention test Behavioral inatention test(minimum of 0 and maximum scores of 146); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of Apraxia screen of Tulia Apraxia screen of (minimum of 0 and maximum scores of 12); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Change of motor evoked potential Amplitude (uV) of motor evoked potential was recorded on abductor pollicis brevis and extentor digitorum brevis following trans-cranial magnetic stimulation for cortico-spinal excitability. 1 day before the initiation of intervention, and 6 months after the stroke onset
Other Change of Weight Weight (Kg) 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Other Change of Temperature temperature (Celsius) 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Other Change of Serum glucose level Serum glucose level (mg/ml) 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Other Change of Hypoglycemia-related severity Assessment of hypoglycemic symptoms using Likert scale (minimum of 0 and maximum scores of 10); higher values and a worse outcome. every day following the start of intervention until 2 weeks of intervention
Primary Change of Surface electromyography root mean square and root peak square of compound motor action potential 1 day before the initiation of intervention, and 6 months after the stroke onset
Secondary Change of Korean-modified Barthel index Korean version-Modified Barthel Index (minimum of 0 and maximum scores of 100); higher values and a better outcome. 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06462599 - Osteopontin Gene Polymorphism in Stroke Patients in Egypt
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A